Zorn Julie A, Wells James A
Department of Pharmaceutical Chemistry and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, California, USA.
Nat Chem Biol. 2010 Mar;6(3):179-188. doi: 10.1038/nchembio.318.
Drug discovery and chemical genetic efforts typically focus on the identification and design of inhibitors or loss-of-function probes as a means to perturb enzyme function. These tools are effective in determining the physiological consequence of ablating the activity of a specific enzyme. Remarkably, nearly a dozen examples of non-natural small molecules that activate enzyme catalysis have been identified within the past decade. In aggregate, these studies delineate four unique activation mechanisms that the small molecules exploit. These complementary gain-of-function probes offer a way to address the sufficiency of an enzyme to drive a particular cellular phenotype, and they also provide new opportunities for drug discovery. This review covers the identification and characterization of these unique small-molecule activators.
药物发现和化学遗传学研究通常专注于抑制剂或功能丧失性探针的鉴定与设计,以此作为干扰酶功能的手段。这些工具在确定消除特定酶活性的生理后果方面很有效。值得注意的是,在过去十年中已鉴定出近十二个激活酶催化作用的非天然小分子实例。总体而言,这些研究描绘了小分子利用的四种独特激活机制。这些互补的功能获得性探针为解决酶驱动特定细胞表型的充分性提供了一种方法,也为药物发现提供了新机会。本综述涵盖了这些独特小分子激活剂的鉴定与表征。